MGRX Mangoceuticals Inc

$MGRX .29.30.31 dips always pay. I could count 20+ times this ran straight back to .50. 5-6 times in 1 day after hours. We love to catch mm sleeping

$MGRX this is looking like its heading to dollars again see chart did it now to long same chart signals going off again

$MGRX According to Mangoceuticals’ annual SEC filings, the company closed 2025 with 15,487,487 common shares outstanding and a total stockholders' equity of $3,281,495 [MGRX 10-K Dec 31 2025]. However, during the first half of 2026, the company ballooning the share count to 29,548,726 shares by June 30, 2026 [MGRX 10-Q June 30 2026]. Assuming no further shares are issued in H2 2026 the evaluation of Book Value per Share (BVPS) Year-End 2026 with shareholders' equity of $ 5,537,482 projected Your true intrinsic book value per share drops from $0.21 to $0.19 (an 11.4% destruction in per-share value). This BVPS proves why the market is currently pricing the stock not at least for 10 Trading sessions in a row above the minimum required $ 1 for NASDAQ compliant listing. The stock trades at a premium around 100 to 150 % to its tangible book value because investors are waiting to see if the company can actually commercialize the remaining 75% of the patent asset before the cash runs dry again.

$MGRX perking here awaiting a new business combo to replace the one that was terminated move to over $1 when it came out

$MGRX I think this has a major potential, and yup. 100% from here by end of year. Yes, It will jump and hit 0,6. Pretty sure I Am

$MGRX The follow up to the post on October, 2nd: Immediate Structural Dilution (Phase 1) Upon closing the offering, the investor was issued 657,000 common shares. Pre-Offering Baseline: 29,548,726 shares. New Share Count: Spikes to 30,205,726 shares. Immediate Ownership Hit: Existing shareholders saw their collective slice shrink by just 2.18% Maximum Cashless Warrant Dilution (Phase 2) When the investor executes the cashless warrant option to claim their fixed payout of 1.08 shares per warrant, an additional 709,560 shares enter the market float without any extra capital injection. • Fully Diluted Share Count: Climbs to 30,915,286 shares. • Total Combined Dilution: Existing shareholders face a total ownership dilution of 4.42% from this single transaction

$MGRX Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close

$MGRX detailed a $0.75 per share securities offering of 657,000 common shares and warrants, raising about $492,750.

$MGRX perking here last news "Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche" perhaps they will have the $$$ now for another business combo

$MGRX < $.50C - Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche